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Comment. This is a rare instance of coincidence of a parasellar
fusiform and berry aneurysm with a chromophobe adenoma
of the pituitary gland. The tumour was clinically silent, except
for a query right hemianopia and a transient left hemiparesis
in the history. According to CourvilJe" (p. 434) a haemorrhage
arising within a pituitary adenoma may break through the capsule
and erode adjacent vessels with consequent haemorrhage from
these. It is difficult to imagine that in this case the bleed from
the internal carotid was due to erosion of this vessel by an ex-
panding pituitary tumour which, on the post-mortem table, was
confined to the intrasellar space (though eroding the posterior
clinoids) and in view of the angiogram demonstrating clearly,
apart from an aneurysm at a common site, a diffuse enlargement
of the internal carotid itself. The necrosis within the adenoma,
extending into the hypothalamus, seems to indicate either a
pressure phaenomenon due to the expanding aneurysmal sac,
or-possibly more consistent with the macroscopic appearance-
consequent on collapse or thrombosis of small feeding arteries
arising from the affected part of the carotid. This, however,
remains open to speculation in view of lack of microscopic con-
firmation.
SUMMARY
In the light of 79 personal cases, surgical emergencies arising
from lesions of the sellar region are discussed under 4
headings. Bilateral macular scotoma leading to rapid decline
of vision calls for differential diagnosis from Vincent's
optochiasmatic arachnoiditis, retrochiasmal extension pro-
ducing Momo blockage, and aneurysms. Cases of imminent
hormonal failure require careful examination and handling
in view of the surgical approach and the operative compli-
cations to be expected, in addition to steroid hormonal
replacement. Three cases of pituitary apoplexy are described
one presenting as an acute mental derangement with halIuci-
n~tions, one showing an eosinophile adenoma, and one with
a combination of aneurysm and a chromophobe adenoma of
the hypophysis.
My sincere thanks go to Prof. W. Tonnis aI\d Prof. H. Krayen-
biihl for permission to include cases treated at their clinics in
Berlin and Zilrich, imd to my former co-workers and assistants
for their invaluable help and advice. '
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NARDIL: A NEW DRUG IN THE TREATMENT OF DEPRESSIVE STATES
J. MACW. MACGREGOR. M.R.e.p. (LoND. AND EOlN.), D.P.M.
A short clinical trial has been made of a new drug and the results
are promising enough to warrant a preliminary communication.
The drug in question is marketed under the trade name of ardil,
has t!le. generic name of phenelzine sulphate, and the chemical
descnptlOn of B-phenylethyl-hydrogen sulphate. It falls under
the group of mono-amine oxidase (MAO) inhibitors, about which
something will be said briefly below.
Dosage. Nardil is supplied in 15-mg. tablets and the usual
dosage is I tablet 3 times daily before meals. In some cases this is
increased so that the patient is given 2 tablets before breakfast
and I tablet before each of the other two main meals of the day.
The aim has been to keep patients on this dosage for 3-4 weeks,
by ,~hich. time the tablets can be reduced to 2 tablets daily for a
varymg time of another 1-4 weeks, and then stopped altogether.
Complicalions. Hypotension, constipation, nausea, and im-
poten~ have been reported in preliminary unpublished data
suppbed by the makers, but did not occur in the present series
t? a degree 'yhich could be labelled 'complication'. The only
SIde-effect whIch was a very definite drawback in certain cases
wa~ the marked increase in tension and irritability in those cases
which presented as depression ....>jth definite underlying agitation
and with heightened anxiety. 0 renal or hepatic disorder oc-
curred. A few patients complained of postural hypotension, but
not t? any marked degree, but a physician who had been taking
ardil and then took alcohol became profoundly hypotensive,
possibly because of potentiation of the hypotensive effects of
the drug.
CASE REPORTS
Case 1. G.H., male, 27 years. Severe depression associated
with feelings of inadequacy and deepened by the death of a relative.
Poor response to ECT. Four weeks after the termination of
ECT, was switched to Nardil and on the sec.ond day of treatment
noted an almost complete lifting of the depression. Has remained
well.
Case 2. B.M., male, 56 years. Moderate to severe depression
for over a year, with great exhaustion, centering around his broken
marriage. Has been on various 'tonics' and had had much psycho-
therapy. Within a week of taking Nardil he returned to activity
and his usual euphoria. Has remained well.
Case 3. E.c., male, 74 years. For 2 years depressed and ex-
hausted and unable to leave home or to play the piano (his main
source of enjoyment). On the second day on Nardil he rang up
excitedly to say he could now practice on the piano for the first
time for 2 years. Has remained well.
Case 4. P.V., male, 60 years. A life-long obsessional with many
rituals and great anxiety, but with depression only secondary
to the difficulties occasioned by compulsive actions of his counting,
repeating of names, etc. Nardil made him over-active and he
found himself in a whirl of obsessional rituals. Unsuccessful.
Case 5. S.F., female, 76 years. Numerous hypochondriacal
fears. Lonely and almost blind. Nardil increased her anxiety
about herself. Unsuccessful.
Case 6. M.V., female, 60 years. Recurrent bouts of depression
with great agitation. Has responded on several occasions to
ECT; no response to Nardil, but discontinued taking the drug
after only 7 days. Unsuccessful.
Case 7. M.G., female, 56 years. Involutional depression in
active. intelligent woman. No previous breakdowns. Main
complaints were of depression, asthenia, and insomnia. Responded
well after first week on Nardil. Has remained well.
.Case 8. A.B., male, 35 years. Long depressive illness in a man
who had enough money to make work unnecessary. Slowly
withdrew from the world and found attempts at any kind of
activity, social or recreative, more and more difficult. Responded
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moderately well to ECf, but soon began to revert to the old
condition until given NardiJ. Has remained well.
Case 9. J.L., female, 48 years. Severe reactive depression
after death of a relative. Did not respond to Imipramine, but is
doing well on Nardil.
Case 10. O.B., male, 35 years. Recurrent episodes of depression
in serious, shy man without obvious external stresses. Various
supportive treatments failed, but within a week of taking ardiJ
he made a remarkable recovery. Has remained well.
Case 11. L.P., female, 35 years. Reactive depression after
death of her father with great feelings of guilt concerning in-
cestuous affair in childhood. Nardil made her over-anxious and
distraught. Unsuccessful.
Case 12. D.T., female, 33 years. Over-protected, anxious
woman, with 2 previous breakdowns on threat of loss of security
(marriage difficulties). Nardil produced great anxiety and florid
psychosomatic symptoms. Unsuccessful.
Case 13. M.G., female, 56 years. Two previous depressive
episodes in a woman with obsessional phobias of having harmed
others. Did quite well on ECf, but made a further definite im-
provement on Nardil almost at once. Remains well.
Case 14. LT., female, 26 years. Marked anxiety with morbid
hypochondriacal ruminations for years. Temporarily helped by
ECf, but not materially improved by NardiJ. Unsuccessful.
Case 15. M.M., female, 34 years. Depression related to numer-
ous operations on back and feet. Great asthenia and depression.
Remains a dependant and inadequate person but is no longer
depressed when taking Nardil. Successful.
These 15 cases can be divided into the following categories and
considered from the viewpoint of satisfactory and unsatisfactory
results:
T~al 9 6
The number of~ studied is too small to give significant
percentage results, but several points arise. Firstly, the results in a
number of cases were dramatic and sustained and, in my opinion,
could not possibly be due to suggestion or coincidental recovery.
Secondly, there is no doubt that agitated states and conditions
with much tension and anxiety are made worse and the patients
complain of a pressure of energy within themselves which is
uncomfortable and frightening. Furthermore, the 2 hypo-
chondriacal cases did not respond, but with the well-known
malign prognosIs in these obsessive depressed cases one is not
at all surprised. Thirdly, the sense of well-being induced by NardiJ
may be different to that induced by amphetamine or methyl-
phenidate (Ritalin), according to 4 patients who have used all 3
drugs; these patients said NardiJ gave them a sense of calm assur-
ance while the two latter drugs gave them a sense of unreality with
their increased energy. Against this my own experience can be
cited: On 3 occasions (without, however, having been depressed)
I took a 15-mg. tablet of NardiJ with a resultant feeling of detached
alertness verging on a feeling of unreality for several hours. This
was not a particularly pleasant feeling and not one which I wish
to repeat. There is no doubt that the drug had a very definite
action and this comment is made to make clear that it should
not be used for its euphorizing effect in normal people. Finally,
some of the failures were due to the patient refusing to continue
with the drug after being on it only a few days without any ap-
parent beneficial effects, so that it is possible that there would
~ave ·been more satisfactory outcomes had the drug been con-
tmued longer. Saunders1 reported that some patients required
to be on phenelzine for 15 days before responding adequately.
I am using Nardil along with ECf in a number of cases not














multiple factors playing a part in the recovery, these cases have
not been reported in this series.
Comment
The classification of depres ive states is almost as complex as
the analysis of the drugs used in the treatment of the conditions.
Lehman' recently pointed out that the approach to the question
of depression could be either phenomenological, aetiological,
somatotypological, nosological, oecological, or neuropharma-
cological. A list such as this brings home the formidable difficulties
in arriving at any satisfactory classification of depres ion. For the
purpose of this paper and with relatively few cases, categorical
complexities had to be avoided.. A simple division under 4 self-
explanatory headings was therefore used: Endogenous depression
(cyclothymic), endogenous depression (hypochondriacal), re-
active depression and involutional depression.
In the assessment of the drug's effect, only two determinants
were used: satisfactory, when the depression lifted and the patient
remained affectively well, and unsatisfactory, when either the
depression remained or treatment had to be discontinued because
of side-effects.
DISCUSSIO
The neuropharmacological treatment of depression has taken a
great step forward in the last 5 years, and Himwich,3 notes 41
drugs recently brought out for use in mental diseases.
The complexities of the biologic amines are far from being
simplified by recent work and there is little point in a detailed
discussion of these matters in a short paper dealing with cli.nical
responses. It seems likely, however, that drugs which inhibit
MAO lead to an increase in central catechol amines and an im-
provement in the general responsiveness of the individual.'
According to Pletscher and Besendorf,5 there are two classes
of MAO inhibitors: (a) Long-acting inhibitors, which are mainly
hydrazine derivatives (Nardil faIls under this heading), and (b) a
shorter acting group which includes amphetamine and harmaline.
The distribution of MAO in the nervous system generally runs
parallel to that of serotonin,· which is found in highest concentra-
tion in the hypothalamus and brainstem. The puzzles of bound
and free serotonin have still to be solved but it appears that MAO
inhibitors cause an increase of serotonin in the brain, while re-
serpine, which has a tranquillizing and sometimes a definite
emotionally depressing effect, allows serotonin to be freed and
metabolized to 5-hydroxyindoleacetic acid.
Another approach to anti-depressive medications has been
taken by Himwich,' who has considered them according to their
effect on the electroencephalogram as either mesodiencephalic
activators or mesodiencephalic blockers and, although there is
no published work along these lines with ardiJ, the possibilities
of combining electrical investigations \vith biochemical refine-
ments gives great promise for the future of antidepressives. It
would seem that phenelzine is a definite step along the road which
will lead to adequate control and reversal of depressive states.
ADDENDUM
Since the completion of this article another series of cases of
depression has been followed up for a period of 2 months. Of a
total of 36 depressive cases 22 made a full and satisfactory re-
covery without the use of ECf.
I should like to thank Messrs. Warner Pharmaceuticals (Pty.)
Ltd. for the generous supply of tablets used in this test.
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